Last reviewed · How we verify
NCT05345392: BEAM
Brain, Emotions, and Mind-Wandering
NA trial testing Mindfulness-Based Intervention (MBI) in Mood Disorders in 140 participants. Currently enrolling.
28 February 2027
Quick facts
| Lead sponsor | University of Pittsburgh |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 140 |
| Start date | 23 September 2022 |
| Primary completion | 28 February 2027 |
| Estimated completion | 28 February 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness-Based Intervention (MBI)
- Health and Wellness Intervention (HWI)
Conditions studied
- Mood Disorders — all drugs for Mood Disorders →
Sponsor
University of Pittsburgh
Who can join
Adults 11 to 14, any sex, with Mood Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mood lability is an important transdiagnostic problem that is associated with poor psychosocial function and suicidal thoughts, and is a predictor of mood disorder onset, especially in youth at familial risk. Thus, particularly in youth with a family history of mood disorder, an intervention to target mood lability during a key period of development could improve outcomes. This study will allow us to test neurobehavioral mechanisms of a mindfulness-based intervention to target mood lability in early adolescents at high risk for developing mood disorders. Through this randomized controlled trial, the investigators will better understand how and for whom mindfulness interventions work, which will lead to more targeted interventions to improve emotion regulation during this key developmental period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05345392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness-Based Intervention (MBI)
Trials testing the same drug.
- NCT07029022 — Monthly Mood Improvement After Workplace Mindfulness · NA · completed
- NCT03514862 — Mindfulness Training for Medical Personnel · NA · completed
Other recruiting trials for Mood Disorders
Currently open trials in the same condition.
- NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
- NCT07362511 — Imagery Rescripting in Primary Care · NA · recruiting
- NCT07211750 — Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT · NA · recruiting
- NCT07088939 — Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course · NA · recruiting
- NCT06412315 — 7T Amygdala and Citalopram Study · NA · recruiting
Other University of Pittsburgh trials
Trials by the same sponsor.
- NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
- NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
- NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
- NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
- NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05345392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
- Last refreshed: 5 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05345392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing